Dirk Theile

1.5k total citations
61 papers, 1.1k citations indexed

About

Dirk Theile is a scholar working on Oncology, Molecular Biology and Pharmacology. According to data from OpenAlex, Dirk Theile has authored 61 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Oncology, 29 papers in Molecular Biology and 16 papers in Pharmacology. Recurrent topics in Dirk Theile's work include Drug Transport and Resistance Mechanisms (29 papers), Pharmacogenetics and Drug Metabolism (15 papers) and Pharmacological Effects and Toxicity Studies (11 papers). Dirk Theile is often cited by papers focused on Drug Transport and Resistance Mechanisms (29 papers), Pharmacogenetics and Drug Metabolism (15 papers) and Pharmacological Effects and Toxicity Studies (11 papers). Dirk Theile collaborates with scholars based in Germany, United States and Czechia. Dirk Theile's co-authors include Johanna Weiß, Walter E. Haefeli, Heike Lindenmaier, Caroline Henrike Storch, Nahal Ketabi‐Kiyanvash, Juan Pablo Rigalli, Jürgen Burhenne, Gerd Mikus, Christel Herold‐Mende and Melanie Herzog and has published in prestigious journals such as PLoS ONE, Analytical Biochemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Dirk Theile

58 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dirk Theile Germany 18 469 331 235 188 129 61 1.1k
Abdelhakim Ahmed‐Belkacem France 17 379 0.8× 502 1.5× 210 0.9× 99 0.5× 117 0.9× 31 1.2k
Rick Greupink Netherlands 24 332 0.7× 302 0.9× 178 0.8× 347 1.8× 163 1.3× 70 1.4k
Kelly Bleasby United States 16 674 1.4× 240 0.7× 165 0.7× 349 1.9× 236 1.8× 21 1.1k
Wen Chyi Shyu United States 23 270 0.6× 408 1.2× 170 0.7× 104 0.6× 219 1.7× 78 1.6k
Romi Ghose United States 19 397 0.8× 444 1.3× 71 0.3× 76 0.4× 297 2.3× 45 1.1k
Michael Török Switzerland 16 418 0.9× 483 1.5× 128 0.5× 235 1.3× 291 2.3× 24 1.3k
Yasuna Kobayashi Japan 19 784 1.7× 350 1.1× 97 0.4× 334 1.8× 267 2.1× 51 1.4k
Poe‐Hirr Hsyu United States 16 230 0.5× 222 0.7× 152 0.6× 96 0.5× 151 1.2× 32 892
Julia Blievernicht Germany 10 510 1.1× 230 0.7× 365 1.6× 170 0.9× 593 4.6× 10 1.3k
Phillip M. Gerk United States 20 429 0.9× 331 1.0× 77 0.3× 254 1.4× 115 0.9× 53 1.2k

Countries citing papers authored by Dirk Theile

Since Specialization
Citations

This map shows the geographic impact of Dirk Theile's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk Theile with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk Theile more than expected).

Fields of papers citing papers by Dirk Theile

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dirk Theile. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk Theile. The network helps show where Dirk Theile may publish in the future.

Co-authorship network of co-authors of Dirk Theile

This figure shows the co-authorship network connecting the top 25 collaborators of Dirk Theile. A scholar is included among the top collaborators of Dirk Theile based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dirk Theile. Dirk Theile is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Köberle, Beate, Sebastian Honnen, Jürgen Burhenne, et al.. (2024). RNA is a pro-apoptotic target of cisplatin in cancer cell lines and C. elegans. Biomedicine & Pharmacotherapy. 173. 116450–116450. 1 indexed citations
4.
5.
6.
Rigalli, Juan Pablo, et al.. (2021). Regulation of PXR Function by Coactivator and Corepressor Proteins: Ligand Binding Is Just the Beginning. Cells. 10(11). 3137–3137. 12 indexed citations
7.
Fresnais, Margaux, Şevin Turcan, Dirk Theile, et al.. (2021). Approaching Sites of Action of Temozolomide for Pharmacological and Clinical Studies in Glioblastoma. Biomedicines. 10(1). 1–1. 10 indexed citations
8.
Longuespée, Rémi, Dirk Theile, Margaux Fresnais, et al.. (2020). Approaching sites of action of drugs in clinical pharmacology: New analytical options and their challenges. British Journal of Clinical Pharmacology. 87(3). 858–874. 13 indexed citations
9.
Sauter, Max, Philipp Uhl, Andreas D. Meid, et al.. (2020). Reporter cell assay-based functional quantification of TNF-α-antagonists in serum – a proof-of-principle study for adalimumab. Analytical Biochemistry. 596. 113646–113646. 2 indexed citations
10.
Rigalli, Juan Pablo, et al.. (2018). The pregnane X receptor (PXR) and the nuclear receptor corepressor 2 (NCoR2) modulate cell growth in head and neck squamous cell carcinoma. PLoS ONE. 13(2). e0193242–e0193242. 10 indexed citations
11.
Theile, Dirk, et al.. (2017). t-Darpp stimulates protein kinase A activity by forming a complex with its RI regulatory subunit. Cellular Signalling. 40. 53–61. 8 indexed citations
12.
Seckinger, Anja, et al.. (2017). Cellular effect and efficacy of carfilzomib depends on cellular net concentration gradient. Cancer Chemotherapy and Pharmacology. 80(1). 71–79. 6 indexed citations
13.
Theile, Dirk & Martin Koš. (2015). Structural and functional evaluation of interaction between mammalian ribosomal RNA with platinum-containing antineoplastic drugs. Toxicology Letters. 242. 47–52. 6 indexed citations
14.
Weiß, Johanna, Sybille Baumann, Dirk Theile, & Walter E. Haefeli. (2014). Desmethyl bosentan displays a similar in vitro interaction profile as bosentan. Pulmonary Pharmacology & Therapeutics. 30. 80–86. 3 indexed citations
15.
Theile, Dirk, Rolf Warta, Juan Pablo Rigalli, et al.. (2014). Antiproliferative efficacies but minor drug transporter inducing effects of paclitaxel, cisplatin, or 5-fluorouracil in a murine xenograft model for head and neck squamous cell carcinoma. Cancer Biology & Therapy. 15(4). 436–442. 8 indexed citations
16.
Seidling, Hanna M., Ulrike Klein, Matthias Schaier, et al.. (2014). What, if all alerts were specific – Estimating the potential impact on drug interaction alert burden. International Journal of Medical Informatics. 83(4). 285–291. 65 indexed citations
17.
Theile, Dirk, et al.. (2013). Watch out for reporter gene assays with Renilla luciferase and paclitaxel. Analytical Biochemistry. 437(2). 109–110. 2 indexed citations
18.
Herzog, Melanie, et al.. (2010). Impact of drug transporters on cellular resistance towards saquinavir and darunavir. Journal of Antimicrobial Chemotherapy. 65(11). 2319–2328. 71 indexed citations
19.
Storch, Caroline Henrike, Dirk Theile, Heike Lindenmaier, Walter E. Haefeli, & Johanna Weiß. (2007). Comparison of the inhibitory activity of anti-HIV drugs on P-glycoprotein. Biochemical Pharmacology. 73(10). 1573–1581. 131 indexed citations
20.
Weiß, Johanna, Dirk Theile, Nahal Ketabi‐Kiyanvash, Heike Lindenmaier, & Walter E. Haefeli. (2006). Inhibition of MRP1/ABCC1, MRP2/ABCC2, and MRP3/ABCC3 by Nucleoside, Nucleotide, and Non-Nucleoside Reverse Transcriptase Inhibitors. Drug Metabolism and Disposition. 35(3). 340–344. 108 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Abdelhakim Ahmed‐Belkacem Breakdown of academic impact, for papers by Rick Greupink Breakdown of academic impact, for papers by Kelly Bleasby Breakdown of academic impact, for papers by Wen Chyi Shyu Breakdown of academic impact, for papers by Romi Ghose Breakdown of academic impact, for papers by Michael Török Breakdown of academic impact, for papers by Yasuna Kobayashi Breakdown of academic impact, for papers by Poe‐Hirr Hsyu Breakdown of academic impact, for papers by Julia Blievernicht Breakdown of academic impact, for papers by Phillip M. Gerk
Rankless by CCL
2026